ArticleChemMedChem2026
Functionalized Cyclic Beta-Amino Acid Derivatives With Antiviral Potential.
Article in ChemMedChem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Selected highly functionalized cyclic beta (β)-amino acid derivatives have been synthesized according to modified and improved literature synthetic protocols and subjected to various antiviral studies. The model compounds were regio- and stereoisomers of azido-functionalized β-amino esters, orthogonally protected diamino esters, an oxirane-fused cyclic β-amino ester, 1,2,3-triazole-substituted β-amino esters, mono- and difluorinated cyclic β-amino esters, mono and dihydroxylated cyclic β-amino esters, dihydroxylated lactams, and β-amino esters with piperidine and azepane skeletons. Formed compounds have been investigated and their anti-HCMV (Human cytomegalovirus), anti-HRV8 (Human rhinovirus 8), and anti-HSV-1 (Human herpesvirus 1) activities were tested (CC50 and IC50 determinations) during screening studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.